Use of Liraglutide (Victoza, Saxenda) & Semaglutide (Ozempic, Wegovy, Rybelsus) Comes with Risk of Gastrointestinal Disorders Use of Liraglutide (Victoza, Saxenda) & Semaglutide (Ozempic, Wegovy, Rybelsus) Tied to Increased Risk for Pancreatitis and Bowel Obstruction A new study showed that use of the GLP1 agonist medications approved for diabetes and weight loss including liraglutide (Victoza, Saxenda) & semaglutide (Ozempic, Wegovy, Rybelsus) come with a 9X increased risk of pancreatitis, 4X increased risk of bowel obstruction and 3.5X increased risk of gastroparesis compared to controls
Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin-A pilot clinical, histologic, and ultrastructural study
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are widely prescribed for type 2 diabetes and weight management
Variability in response across individuals
Researchers studying pigmentation and hormonal pathways need to understand Melanotan 1 vs Melanotan 2
The pink gelatin trick is promoted online as a pre meal ritual : you dissolve unflavored gelatin in a hot liquid, optionally add a pink flavor usually cranberry or pomegranate juice, then drink it warm or chill it into a soft gel